{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:56:30Z","timestamp":1789736190454,"version":"4.0.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Cariplo Foundation (Scientific Research in Biomedicine 2011)"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.euroneuro.2014.09.016","type":"journal-article","created":{"date-parts":[[2014,10,23]],"date-time":"2014-10-23T02:05:59Z","timestamp":1414029959000},"page":"1470-1479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Novel dimensions of D3 receptor function: Focus on heterodimerisation, transactivation and allosteric modulation"],"prefix":"10.1016","volume":"25","author":[{"given":"Roberto","family":"Maggio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Scarselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Capannolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Millan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2014.09.016_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brainres.2003.09.082","article-title":"The novel antipsychotic aripiprazole is a partial agonist at short and long isoforms of D2 receptors linked to the regulation of adenylyl cyclase activity and prolactin release","volume":"1003","author":"Aihara","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.pharmthera.2011.07.004","article-title":"Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson\u05f3s disease","volume":"132","author":"Armentero","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib3","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/npp.2008.144","article-title":"Dopamine D2 and adenosine A2A receptors regulate NMDA-mediated excitation in accumbens neurons through A2A-D2 receptor heteromerization","volume":"34","author":"Azdad","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.09.016_bib4","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0022-2836(03)00439-X","article-title":"Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein","volume":"329","author":"Ban\u00e8res","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib5","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nm875","article-title":"Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function","volume":"9","author":"B\u00e9zard","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib6","doi-asserted-by":"crossref","first-page":"42578","DOI":"10.1074\/jbc.M306165200","article-title":"Dimers of class A G protein-coupled receptors function via agonist-mediated trans-activation of associated G proteins","volume":"278","author":"Carrillo","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib7","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s11064-010-0359-0","article-title":"Neurofibromin and amyloid precursor protein expression in dopamine D3 receptor knock-out mice brains","volume":"36","author":"Castorina","year":"2011","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib8","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1126\/science.1197410","article-title":"Structure of the human dopamine D3 receptor in complex with a D2\/D3 selective antagonist","volume":"330","author":"Chien","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.euroneuro.2014.09.016_bib9","doi-asserted-by":"crossref","first-page":"19208","DOI":"10.1073\/pnas.0506627102","article-title":"Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series","volume":"102","author":"Daniels","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.euroneuro.2014.09.016_bib10","doi-asserted-by":"crossref","first-page":"8677","DOI":"10.1523\/JNEUROSCI.20-23-08677.2000","article-title":"Dopamine D3 receptors expressed by all mesencephalic dopamine neurons","volume":"20","author":"Diaz","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib11","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2174\/187152710793361603","article-title":"Prime time for G-protein-coupled receptor heteromers as therapeutic targets for CNS disorders: the dopamineD(1)-D(3) receptor heteromer","volume":"9","author":"Ferr\u00e9","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.euroneuro.2014.09.016_bib12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/pr.113.008052","article-title":"G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives","volume":"66","author":"Ferr\u00e9","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1124\/mol.107.043885","article-title":"Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization","volume":"74","author":"Fiorentini","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib14","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00702-003-0059-x","article-title":"Dopamine receptor agonists in the therapy of Parkinson\u05f3s disease","volume":"111","author":"Foley","year":"2004","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0091-3057(99)00240-3","article-title":"Effects of ropinirole on various parkinsonian models in mice, rats, and cynomolgus monkeys","volume":"65","author":"Fukuzaki","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35075076","article-title":"BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization","volume":"411","author":"Guillin","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2014.09.016_bib17","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nchembio.199","article-title":"Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation","volume":"5","author":"Han","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib18","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/25348","article-title":"GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2","volume":"396","author":"Jones","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2014.09.016_bib19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.coph.2006.11.004","article-title":"Dopamine D3 receptor agonists for protection and repair in Parkinson\u05f3s disease","volume":"7","author":"Joyce","year":"2007","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/cmdc.201100499","article-title":"Selective agonists for dopamine\/neurotensin receptor heterodimers","volume":"7","author":"Koschatzky","year":"2012","journal-title":"Chem. Med. Chem."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib21","doi-asserted-by":"crossref","first-page":"35671","DOI":"10.1074\/jbc.M401923200","article-title":"Dopamine D1 and D2 receptor coactivation generates a novel phospholipase C-mediated calcium signal","volume":"279","author":"Lee","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib22","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1073\/pnas.90.7.3103","article-title":"Coexpression studies with mutant muscarinic\/adrenergic receptors provide evidence for intermolecular \u201ccross-talk\u201d between G-protein-linked receptors","volume":"90","author":"Maggio","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.euroneuro.2014.09.016_bib23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1046\/j.1471-4159.2003.02038.x","article-title":"Potent activation of dopamine D3\/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole","volume":"87","author":"Maggio","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib24","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1111\/j.1471-4159.2007.04896.x","article-title":"G protein-coupled receptor oligomerization provides the framework for signal discrimination","volume":"103","author":"Maggio","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib25","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1353-8020(09)70826-0","article-title":"Heterodimerization of dopamine receptors: new insights into functional and therapeutic significance","volume":"15","author":"Maggio","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.euroneuro.2014.09.016_bib26","first-page":"004","article-title":"The quaternary structure of dopamine D2 and D3 receptors: comparisons of the homo-oligomerisation of two closely related G protein-coupled receptors","volume":"12","author":"Marsango","year":"2014","journal-title":"Proc. Br. Pharmacol. Soc."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib27","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1097\/00002826-199501001-00021","article-title":"Pramipexole: a dopamine-receptor agonist for treatment of Parkinson\u05f3s disease","volume":"18","author":"Mierau","year":"1995","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib28","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1124\/jpet.102.039867","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes","volume":"303","author":"Millan","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib29","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1124\/jpet.103.062414","article-title":"S32504, a novel naphtoxazine agonist at dopamine D3\/D2 receptors: II. Actions in rodent, primate, and cellular models of antiparkinsonian activity in comparison to ropinirole","volume":"309","author":"Millan","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib30","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1124\/jpet.103.062463","article-title":"S32504, a novel naphtoxazine agonist at dopamine D3\/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropinirole","volume":"309","author":"Millan","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2515\/therapie:2008041","article-title":"Cognitive impairment in schizophrenia: a review of developmental and genetic models, and pro-cognitive profile of the optimised D(3) and D(2) antagonist, S33138","volume":"63","author":"Millan","year":"2008","journal-title":"Therapie"},{"key":"10.1016\/j.euroneuro.2014.09.016_bib32","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.euroneuro.2014.03.008","article-title":"Negative symptoms of schizophrenia: clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment","volume":"24","author":"Millan","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib33","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/syn.20325","article-title":"Dopamine (D2\/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo","volume":"60","author":"Narendran","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.euroneuro.2014.09.016_bib34","doi-asserted-by":"crossref","first-page":"27346","DOI":"10.1074\/jbc.M110.115634","article-title":"Interactions between intracellular domains as key determinants of the quaternary structure and function of receptor heteromers","volume":"285","author":"Navarro","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib35","doi-asserted-by":"crossref","first-page":"29229","DOI":"10.1074\/jbc.272.46.29229","article-title":"Expression of dopamine D3 receptor dimers and tetramers in brain and in transfected cells","volume":"272","author":"Nimchinsky","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib36","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/j.1471-4159.2007.04660.x","article-title":"Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: potential role of heterodimer formation","volume":"102","author":"Novi","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbrc.2011.11.027","article-title":"Two amino acids in each of D1 and D2 dopamine receptor cytoplasmic regions are involved in D1-D2 heteromer formation","volume":"417","author":"O\u05f3Dowd","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib38","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.bbrc.2012.12.139","article-title":"D5 dopamine receptor carboxyl tail involved in D5-D2 heteromer formation","volume":"431","author":"O\u05f3Dowd","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/mp.2010.106","article-title":"Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine\/D2 pathways","volume":"17","author":"Papaleo","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.09.016_bib40","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/nm.2263","article-title":"Uncoupling the dopamine D1-D2 receptor complex exerts antidepressant-like effects","volume":"16","author":"Pei","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib41","first-page":"1","article-title":"A physiological role for the dopamine D5 receptor as a regulator of BDNF and Akt signalling in rodent prefrontal cortex","volume":"25","author":"Perreault","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib42","doi-asserted-by":"crossref","first-page":"8864","DOI":"10.1074\/jbc.M111.326678","article-title":"Functional homomers and heteromers of dopamine D2L and D3 receptors co-exist at the cell surface","volume":"287","author":"Pou","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib43","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature10361","article-title":"Crystal structure of the \u03b22 adrenergic receptor-Gs protein complex","volume":"477","author":"Rasmussen","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2014.09.016_bib44","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1046\/j.1471-4159.1996.67010212.x","article-title":"Chimeric D2\/D3 dopamine receptors efficiently inhibit adenylyl cyclase in HEK 293 cells","volume":"67","author":"Robinson","year":"1996","journal-title":"J Neurochem"},{"key":"10.1016\/j.euroneuro.2014.09.016_bib45","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0014-2999(00)00272-7","article-title":"Reconstitution of functional dopamine D(2s) receptor by co-expression of amino- and carboxyl-terminal receptor fragments","volume":"397","author":"Scarselli","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib46","doi-asserted-by":"crossref","first-page":"30308","DOI":"10.1074\/jbc.M102297200","article-title":"D2\/D3 dopamine receptor heterodimers exhibit unique functional properties","volume":"276","author":"Scarselli","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib47","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0006-8993(03)03360-2","article-title":"Functional rescue of the inactive splice variant of the dopamine D3 receptor D3nf","volume":"987","author":"Scarselli","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib48","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/syn.20298","article-title":"Dopamine D2 and D3 receptors in human putamen, caudate nucleus and globus pallidus","volume":"60","author":"Seeman","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.euroneuro.2014.09.016_bib49","series-title":"Identification of bitopic and allosteric ligands targeting the dopamine D2 receptor. G-protein-coupled-receptors: from structural insights to functional mechanisms.","first-page":"12","author":"Shonberg","year":"2012"},{"key":"10.1016\/j.euroneuro.2014.09.016_bib50","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1124\/mol.110.065755","article-title":"The tetrahydroisoquinoline derivative SB269,652 is an allosteric antagonist at dopamine D3 and D2 receptors","volume":"78","author":"Silvano","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib51","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/1568007024606195","article-title":"Partial dopamine agonists and dopaminergic stabilizers, in the treatment of psychosis","volume":"1","author":"Tamminga","year":"2002","journal-title":"Curr. Drug. Targets CNS Neurol. Disord."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib52","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1124\/mol.104.003376","article-title":"Adenosine A2A receptor and dopamine D3 receptor interactions: evidence of functional A2A\/D3 heteromeric complexes","volume":"67","author":"Torvinen","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.euroneuro.2014.09.016_bib53","doi-asserted-by":"crossref","first-page":"7682","DOI":"10.1073\/pnas.0611448104","article-title":"A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein","volume":"104","author":"Whorton","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14002806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14002806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T10:48:45Z","timestamp":1565952525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X14002806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0924977X14002806"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2014.09.016","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel dimensions of D3 receptor function: Focus on heterodimerisation, transactivation and allosteric modulation","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2014.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}